Gail Page has stepped down as chairman of the board at Vermillion. Page will still remain CEO. In her place, the company elected James Burns as chairman.
Burns has been a director of the board since 2005, and is the president and CEO of AssureRx. Previously he was president and CEO of EntreMed.
Waters has recognized the University of Minnesota's Mass Spectrometry Laboratory as a Waters Center of Innovation, citing in particular the work of the facility's head Joseph Dalluge.
Dalluge is the thirteenth researcher recognized by the program. His research focuses on diagnostic marker development for cystic fibrosis and other diseases, using LC-MS instruments including Waters' Aqcuity UPLC/TQD and Synapt G2 for metabolite profiling, biomarker discovery, and chemical characterization of biological systems.